From intravenous to enteral ketogenic diet in PICU: A potential treatment strategy for refractory status epilepticus

F. Chiusolo, A. Diamanti, R. Bianchi, L. Fusco, M. Elia, T. Capriati, F. Vigevano, S. Picardo

Research output: Contribution to journalArticle

Abstract

Background Ketogenic diet (KD) has been used to treat refractory status epilepticus (RSE). KD is a high-fat, restricted-carbohydrate regimen that may be administered with different fat to protein and carbohydrate ratios (3:1 and 4:1 fat to protein and carbohydrate ratios). Other ketogenic regimens have a lower fat and higher protein and carbohydrate ratio to improve taste and thus compliance to treatment. We describe a case of RSE treated with intravenous KD in the Pediatric Intensive Care Unit (PICU). Case report An 8-year-old boy was referred to the PICU because of continuous tonic-clonic and myoclonic generalized seizures despite several antiepileptic treatments. After admission he was intubated and treated with intravenous thiopental followed by ketamine. Seizures continued with frequent myoclonic jerks localized on the face and upper arms. EEG showed seizure activity with spikes on rhythmic continuous waves. Thus we decided to begin KD. The concomitant ileus contraindicated KD by the enteral route and we therefore began IV KD. The ketogenic regimen consisted of conventional intravenous fat emulsion, plus dextrose and amino-acid hyperalimentation in a 2:1 then 3:1 fat to protein and carbohydrate ratio. Exclusive IV ketogenic treatment, well tolerated, was maintained for 3 days; peristalsis then reappeared so KD was continued by the enteral route at 3:1 ratio. Finally, after 8 days and no seizure improvement, KD was deemed unsuccessful and was discontinued. Conclusions Our experience indicates that IV KD may be considered as a temporary “bridge” towards enteral KD in patients with partial or total intestinal failure who need to start KD. It allows a prompt initiation of KD, when indicated for the treatment of severe diseases such as RSE.

Original languageEnglish
Pages (from-to)843-847
Number of pages5
JournalEuropean Journal of Paediatric Neurology
Volume20
Issue number6
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Ketogenic Diet
Pediatric Intensive Care Units
Status Epilepticus
Small Intestine
Fats
Carbohydrates
Seizures
Therapeutics
Proteins
Intravenous Fat Emulsions
Peristalsis
Myoclonus
Thiopental
Ileus
Ketamine
Anticonvulsants

Keywords

  • Children
  • Intestinal failure
  • Ketogenic diet
  • Pediatric intensive care unit
  • Refractory status epilepticus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

@article{4551aa38882247fa87daafa5aca45702,
title = "From intravenous to enteral ketogenic diet in PICU: A potential treatment strategy for refractory status epilepticus",
abstract = "Background Ketogenic diet (KD) has been used to treat refractory status epilepticus (RSE). KD is a high-fat, restricted-carbohydrate regimen that may be administered with different fat to protein and carbohydrate ratios (3:1 and 4:1 fat to protein and carbohydrate ratios). Other ketogenic regimens have a lower fat and higher protein and carbohydrate ratio to improve taste and thus compliance to treatment. We describe a case of RSE treated with intravenous KD in the Pediatric Intensive Care Unit (PICU). Case report An 8-year-old boy was referred to the PICU because of continuous tonic-clonic and myoclonic generalized seizures despite several antiepileptic treatments. After admission he was intubated and treated with intravenous thiopental followed by ketamine. Seizures continued with frequent myoclonic jerks localized on the face and upper arms. EEG showed seizure activity with spikes on rhythmic continuous waves. Thus we decided to begin KD. The concomitant ileus contraindicated KD by the enteral route and we therefore began IV KD. The ketogenic regimen consisted of conventional intravenous fat emulsion, plus dextrose and amino-acid hyperalimentation in a 2:1 then 3:1 fat to protein and carbohydrate ratio. Exclusive IV ketogenic treatment, well tolerated, was maintained for 3 days; peristalsis then reappeared so KD was continued by the enteral route at 3:1 ratio. Finally, after 8 days and no seizure improvement, KD was deemed unsuccessful and was discontinued. Conclusions Our experience indicates that IV KD may be considered as a temporary “bridge” towards enteral KD in patients with partial or total intestinal failure who need to start KD. It allows a prompt initiation of KD, when indicated for the treatment of severe diseases such as RSE.",
keywords = "Children, Intestinal failure, Ketogenic diet, Pediatric intensive care unit, Refractory status epilepticus",
author = "F. Chiusolo and A. Diamanti and R. Bianchi and L. Fusco and M. Elia and T. Capriati and F. Vigevano and S. Picardo",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.ejpn.2016.08.004",
language = "English",
volume = "20",
pages = "843--847",
journal = "European Journal of Paediatric Neurology",
issn = "1090-3798",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - From intravenous to enteral ketogenic diet in PICU

T2 - A potential treatment strategy for refractory status epilepticus

AU - Chiusolo, F.

AU - Diamanti, A.

AU - Bianchi, R.

AU - Fusco, L.

AU - Elia, M.

AU - Capriati, T.

AU - Vigevano, F.

AU - Picardo, S.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Background Ketogenic diet (KD) has been used to treat refractory status epilepticus (RSE). KD is a high-fat, restricted-carbohydrate regimen that may be administered with different fat to protein and carbohydrate ratios (3:1 and 4:1 fat to protein and carbohydrate ratios). Other ketogenic regimens have a lower fat and higher protein and carbohydrate ratio to improve taste and thus compliance to treatment. We describe a case of RSE treated with intravenous KD in the Pediatric Intensive Care Unit (PICU). Case report An 8-year-old boy was referred to the PICU because of continuous tonic-clonic and myoclonic generalized seizures despite several antiepileptic treatments. After admission he was intubated and treated with intravenous thiopental followed by ketamine. Seizures continued with frequent myoclonic jerks localized on the face and upper arms. EEG showed seizure activity with spikes on rhythmic continuous waves. Thus we decided to begin KD. The concomitant ileus contraindicated KD by the enteral route and we therefore began IV KD. The ketogenic regimen consisted of conventional intravenous fat emulsion, plus dextrose and amino-acid hyperalimentation in a 2:1 then 3:1 fat to protein and carbohydrate ratio. Exclusive IV ketogenic treatment, well tolerated, was maintained for 3 days; peristalsis then reappeared so KD was continued by the enteral route at 3:1 ratio. Finally, after 8 days and no seizure improvement, KD was deemed unsuccessful and was discontinued. Conclusions Our experience indicates that IV KD may be considered as a temporary “bridge” towards enteral KD in patients with partial or total intestinal failure who need to start KD. It allows a prompt initiation of KD, when indicated for the treatment of severe diseases such as RSE.

AB - Background Ketogenic diet (KD) has been used to treat refractory status epilepticus (RSE). KD is a high-fat, restricted-carbohydrate regimen that may be administered with different fat to protein and carbohydrate ratios (3:1 and 4:1 fat to protein and carbohydrate ratios). Other ketogenic regimens have a lower fat and higher protein and carbohydrate ratio to improve taste and thus compliance to treatment. We describe a case of RSE treated with intravenous KD in the Pediatric Intensive Care Unit (PICU). Case report An 8-year-old boy was referred to the PICU because of continuous tonic-clonic and myoclonic generalized seizures despite several antiepileptic treatments. After admission he was intubated and treated with intravenous thiopental followed by ketamine. Seizures continued with frequent myoclonic jerks localized on the face and upper arms. EEG showed seizure activity with spikes on rhythmic continuous waves. Thus we decided to begin KD. The concomitant ileus contraindicated KD by the enteral route and we therefore began IV KD. The ketogenic regimen consisted of conventional intravenous fat emulsion, plus dextrose and amino-acid hyperalimentation in a 2:1 then 3:1 fat to protein and carbohydrate ratio. Exclusive IV ketogenic treatment, well tolerated, was maintained for 3 days; peristalsis then reappeared so KD was continued by the enteral route at 3:1 ratio. Finally, after 8 days and no seizure improvement, KD was deemed unsuccessful and was discontinued. Conclusions Our experience indicates that IV KD may be considered as a temporary “bridge” towards enteral KD in patients with partial or total intestinal failure who need to start KD. It allows a prompt initiation of KD, when indicated for the treatment of severe diseases such as RSE.

KW - Children

KW - Intestinal failure

KW - Ketogenic diet

KW - Pediatric intensive care unit

KW - Refractory status epilepticus

UR - http://www.scopus.com/inward/record.url?scp=84989245097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989245097&partnerID=8YFLogxK

U2 - 10.1016/j.ejpn.2016.08.004

DO - 10.1016/j.ejpn.2016.08.004

M3 - Article

AN - SCOPUS:84989245097

VL - 20

SP - 843

EP - 847

JO - European Journal of Paediatric Neurology

JF - European Journal of Paediatric Neurology

SN - 1090-3798

IS - 6

ER -